Mori Arkin
Co-Founder Partner @ Sphera Global Healthcare Fund
Mori Arkin is a seed investor at Sphera Global Healthcare Fund focused on Men's and Medical. Mori Arkin is based out of Israel and is the Founder and Chairman of Arkin Capital. Mori Arkin attended Tel Aviv University.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Mori Arkin invests in
Stages Mori Arkin invests in
Countries Mori Arkin invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Men's 1 (100%)
- Medical 1 (100%)
- Health Care 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Butterfly Medical
|
Butterfly Medical is a medical-device start-up that aims to improve the standard of care for men suffering from Benign Prostate Hyperplasia (BPH) or enlarged prostate. The company has developed a fast, simple and minimally invasive alternative treatment to first-line BPH medication and surgery. Butterfly Medical’s patented device can beplaced in under 10 minutes, in-office, under local anesthesia, without surgical incision, heating or prostate tissue removal. The device aims to be the only in-office BPH treatment that delivers a long-term, effective solution with minimal side effects, requiring no hospitalization or general anesthesia. Early results from clinical trials are very promising with blocked urethras successfully opened and patients suffering no side effects. Further clinical studies are starting in leading medical centers in Europe.Visit www.butterfly-medical.com for more information. | $2M / Seed / Jan 29, 2020 |
Sphera Global Healthcare Management (Investment Manager) is a partnership between Mr. Mori Arkin, former vice chairman of Perrigo (Nasdaq ticker:PRGO, a world leader in generic and OTC drugs), and of Sphera Funds Management.It is a long/short equity fund that is focused on the global pharmaceutical and biotech industries. The InvestmentManager’s objective is to generate consistent and attractive long term returns exceeding the industry while maintaining disciplined risk management. With a highly experienced and cohesive multidisciplinary team, the Fund’s competitive advantage is evident in three key areas:• Having a rigorous, fundamental, focused and comprehensive approach to healthcare research.• Investment committee co- led by an industry veteran with a track record of building a pharmaceutical company.• Unique and unbiased investment approach generated in part from access to massive flow of R &D, innovation and top tier human capital in Israel.
Sphera Global Healthcare Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Amit Drach
Senior Scientific Analyst
|
|||
Doron Breen
Partner and Fund Manager
|
|||
Geula Schwartz
Analyst
|
|||
Hagai Schor
Head of Scientific Research
|
|||
Joon Lee
Analyst
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Mori Arkin invest in?
Mori Arkin invests primarily in Men's, Medical and Health Care startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Mori Arkin?
Public channels for Mori Arkin include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Mori Arkin last invest?
The most recent investment recorded for Mori Arkin closed in Jan 2020. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
